Ubiquitous Pharmacogenomics (U-PGx)
  • Home
  • U-PGx
    • U-PGx Consortium
    • Work Packages
    • Deliverables
    • U-PGx Publications
    • Ethics
    • Scientific Advisory Board
  • PREPARE
    • Study Overview
    • Results
    • Pharmacogenomics guidelines (DPWG)
    • FAQ
    • Downloads & Web Resources
    • LIM Survey
    • Data Collection
    • Ethics
  • Education
    • Education material
    • Events Calendar
    • Upcoming U-PGx Events
    • Past U-PGx Events
    • Links
    • Other PGx Organizations
      • PGRN
  • News
  • Login Members
  • Contact

Mary Relling joins U-PGx advisory board

Posted on May 17, 2016May 17, 2016 by WEB ADMIN

Mary Relling is a scientist at St. Jude Children’s Research Hospital where she is a member of the St. Jude Faculty, chair of the Pharmaceutical Sciences Department and she leads the CPIC initiative.

This entry was posted in News. Bookmark the permalink.

Post navigation

← Group photo from kick-off meeting
U-PGx collaborates with Teri Klein, co-principal investigator of PharmGKB and CPIC →

Recent Posts

  • Matching medication to DNA leads to 30% fewer side effects
  • U-PGx Personalized Medicine Symposium
  • bio.logis receives the E-Health Award Hessen 2021
  • 7th U-PGx Personalized Medicine Day
  • Dr. Cristina Lucía Dávila Fajardo obtains PhD degree in pharmacogenetics
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668353.